Small Caps – PharmAust assembles world-class scientific advisory board to propel fight against neurodegenerative diseases MediaBy Nickholas Bahr22/02/2024
Stockhead – PharmAust forms scientific advisory board to guide next phase of monepantel for treatment of MND/ALS MediaBy Nickholas Bahr22/02/2024
ALS News Today – FDA, PharmAust to meet over plans for Phase 2/3 trial of monepantel MediaBy Nickholas Bahr09/01/2024
Stockhead – PharmAust just got a pre-IND meeting with the US FDA to kick off ‘24 MediaBy Nickholas Bahr02/01/2024
Stockhead – Santa (and ATO) delivers PharmAust $550k cash boost for Christmas MediaBy Nickholas Bahr30/12/2023
The Advertiser – (More) ASX biotechs with catalysts that could make them pop in 2024 MediaBy Nickholas Bahr29/12/2023
Stockhead – Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust MediaBy Nickholas Bahr22/12/2023
